Sotera Health Company (NASDAQ:SHC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been given an average rating of “Moderate Buy” by the eleven research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $20.25.

A number of brokerages recently weighed in on SHC. Piper Sandler reissued an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Barclays raised their price objective on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. Finally, Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 15.36% of the company’s stock.

Institutional Trading of Sotera Health

Several hedge funds have recently made changes to their positions in the company. IFP Advisors Inc increased its holdings in Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares during the last quarter. Rothschild Investment LLC purchased a new stake in Sotera Health during the fourth quarter valued at about $27,000. Root Financial Partners LLC lifted its holdings in Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after purchasing an additional 1,455 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the period. Finally, Eurizon Capital SGR S.p.A. bought a new position in Sotera Health during the fourth quarter worth about $40,000. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Performance

Shares of SHC opened at $17.98 on Thursday. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The company has a market capitalization of $5.13 billion, a price-to-earnings ratio of 43.85 and a beta of 1.77. The stock has a 50 day moving average of $17.00 and a 200 day moving average of $16.32. Sotera Health has a 12 month low of $11.00 and a 12 month high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. The business had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, sell-side analysts forecast that Sotera Health will post 0.87 earnings per share for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.